Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Transplant Proc ; 48(7): 2306-2309, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27742285

ABSTRACT

INTRODUCTION: Invasive fungal disease (IFD) is an important complication after solid organ transplantation (SOT). A marked geographic variation in the epidemiology of IFD after kidney transplantation (KT) has been suggested by the results of previous studies. Nevertheless, data from Latin American centers are scarce. OBJECTIVE: This study sought to describe the epidemiology of IFD at a Brazilian KT center. METHODS: This study was a retrospective single-center cohort study that included patients who underwent KT between 1998 and 2009 and were followed up until July 2015. Cases of simultaneous kidney-pancreas transplantation were excluded. The primary study outcome was the occurrence of proven or probable IFD. RESULTS: Among 908 KT recipients, 44 cases of IFD occurred in 42 patients (4.6%). Cryptococcus spp. infection, diagnosed in 16 cases (36.3%), was the leading cause of IFD, followed by histoplasmosis in 10 cases (22.7%) and invasive candidiasis in 10 (22.7%). Sporotrichosis, mucormycosis, invasive aspergillosis, pulmonary Cladophialophora sp. infection, trichosporonosis and Saccharomyces cerevisiae fungemia occurred in 1 recipient each (2.3%). Two additional (4.5%) cases of unspecified mold infections were identified by histopathological analysis. Most cases of IFD (67%) occurred later than 6 months after transplantation. Previous use of antilymphocyte antibodies (P = .008) and corticosteroid pulse therapy (P < .001) were more frequent among cases of IFD occurring within the first 6 months after transplantation. CONCLUSIONS: The epidemiology of IFD in this Brazilian cohort was characterized by a large predominance of late infections and a high proportion of cases of cryptococcosis and histoplasmosis. These results highlight the considerable geographic variability of IFD epidemiology after KT.


Subject(s)
Antilymphocyte Serum/therapeutic use , Graft Rejection/prevention & control , Immunosuppressive Agents/therapeutic use , Kidney Transplantation , Mycoses/epidemiology , Postoperative Complications/epidemiology , Adult , Brazil/epidemiology , Candidiasis, Invasive/epidemiology , Cryptococcosis/epidemiology , Female , Histoplasmosis/epidemiology , Humans , Invasive Pulmonary Aspergillosis/epidemiology , Male , Middle Aged , Mucormycosis/epidemiology , Retrospective Studies , Risk Factors , Transplant Recipients
2.
Am J Transplant ; 13(12): 3230-5, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24119248

ABSTRACT

This retrospective cohort study assessed the results of the implementation of preventive recommendations for tuberculosis (TB) among renal transplant recipients in an endemic area (Rio de Janeiro, Brazil). Subjects were defined as at high risk for TB if they had latent tuberculosis infection (LTBI), reported recent close contact with individuals with TB or received a graft from a donor with LTBI. A 6-month course of isoniazid preventive therapy (IPT) was targeted to high-risk subjects. The study end point was TB confirmed by culture. Altogether, 535 patients were included. Median follow-up was 59 months. The overall cumulative incidence of TB was 2.1% while among the 274 patients in whom the preventive protocol was fully implemented, the incidence was only 0.7%. The incidence of TB among 75 high-risk recipients not treated with isoniazid (7%) was significantly higher than that observed in 209 untreated low-risk patients (1%, p = 0.006) and in 65 high-risk subjects that received IPT (no case, p = 0.03). In conclusion, the implementation of preventive recommendations for TB in an endemic area allowed the appropriate discrimination between high- and low-risk renal transplant recipients and was associated with long-term reduction in the incidence of this complication among high-risk subjects.


Subject(s)
Kidney Transplantation , Renal Insufficiency/complications , Tuberculosis/prevention & control , Adult , Antitubercular Agents/therapeutic use , Brazil , Female , Follow-Up Studies , Humans , Incidence , Isoniazid/therapeutic use , Male , Middle Aged , Outcome Assessment, Health Care , Program Evaluation , Proportional Hazards Models , Renal Insufficiency/therapy , Retrospective Studies , Risk
3.
Arq. bras. med. vet. zootec ; 60(3): 762-765, jun. 2008. tab
Article in Portuguese | LILACS | ID: lil-487926

ABSTRACT

The antimicrobial resistance of 96 Escherichia coli strains isolated from a stabilization pond system on a pig-breeding farm was evaluated. Strains were tested for their resistance against 14 antimicrobial using the agar diffusion method. E. coli strains showed resistance to tetracycline (82.3 percent), nalidixic acid (64 percent), ampicilin (41 percent), sulfamethoxazole/trimethoprin (36 percent), sulfonamide (34 percent), cloranphenicol (274 percent), ciprofloxacin (19 percent), cefaclor (16 percent), streptomicyn (7.3 percent), neomicyn (1 percent), amoxacilin/ clavulanic acid (1 percent), and amikacin (1 percent). No resistance was observed to gentamicin and tobramycin, and 37.5 percent of E. coli strains were resistant to four or more antimicrobials. The multiresistance pattern was found in strains isolated during all sampled period. Strains showed a high variability in the antimicrobial resistance pattern.


Subject(s)
Animals , Drug Resistance , Drug Resistance, Microbial , Escherichia coli/isolation & purification , Feces/microbiology , Swine
4.
J Gastrointest Surg ; 11(2): 199-203, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17390173

ABSTRACT

In the megaesophagus of Chagas' disease, chronic esophagitis is caused by stasis of swallowed food and saliva. In this environment, the overgrowth of aerobic and anaerobic bacteria, including nitrate-reducing bacteria, is observed. The reduction of nitrate into nitrite by the action of these bacteria has been associated with the formation of volatile nitrosamines in different situations of gastric bacterial overgrowth. We have hypothesized that this phenomenon could occur in the esophageal lumen of patients with megaesophagus. To evaluate the concentration of nitrite, the presence of volatile nitrosamines and the concentration of nitrate-reducing bacteria in the esophageal lumen of patients with non-advanced megaesophagus of Chagas' disease and in a group of patients without esophageal disease. Fifteen patients with non-advanced megaesophagus [megaesophagus group (MG)] and 15 patients without any esophageal disease [control group (CG)] were studied. Saliva samples were taken for nitrate and nitrite quantitative determination and esophageal stasis liquid samples were taken for nitrate and nitrite quantitative determination, volatile nitrosamines qualitative determination and reductive bacteria quantitative determination. MG and CG were equivalent in nitrate and nitrite saliva concentration and in nitrate esophageal concentration. Significant difference was found in nitrite (p = 0.003) and reductive bacteria concentration (p < 0.0001), both higher in MG. Volatile nitrosamines were identified in three MG patients and in none of the CG patients, but this was not significant (p = 0.113). There is a higher concentration of reductive bacteria in MG, responsible for the rise in nitrite concentration at the esophageal lumen and, eventually, for the formation of volatile nitrosamines.


Subject(s)
Bacteria/isolation & purification , Chagas Disease/microbiology , Esophageal Achalasia/microbiology , Esophagus/microbiology , Nitrates/metabolism , Nitrites/metabolism , Adult , Aged , Bacteria/metabolism , Chagas Disease/complications , Esophageal Achalasia/complications , Female , Humans , Male , Middle Aged , Nitrosamines/metabolism , Saliva/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...